ASX - By Stock
|
YOJ |
Re:
Ann: Consolidation/Split - YOJ
|
|
charlirose
|
12 |
8.1K |
2 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
12
|
8.1K
|
2
|
|
ASX - By Stock
|
ASN |
Re:
ASN General Discussion
|
|
charlirose
|
19K |
5.6M |
5 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
19K
|
5.6M
|
5
|
|
ASX - By Stock
|
XTC |
Re:
Ann: Quarterly Activities Report Dec 2023
|
|
charlirose
|
27 |
10K |
1 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
27
|
10K
|
1
|
|
ASX - By Stock
|
HAS |
Re:
Ann: Binding Term Sheet Signed for Integrated Tolling and Offtake
|
|
charlirose
|
17 |
10K |
3 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
17
|
10K
|
3
|
|
ASX - By Stock
|
BRN |
Re:
2024 BrainChip Discussion
|
|
charlirose
|
4.8K |
1.8M |
3 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
4.8K
|
1.8M
|
3
|
|
ASX - By Stock
|
ASN |
Re:
ASN General Discussion
|
|
charlirose
|
19K |
5.6M |
4 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
19K
|
5.6M
|
4
|
|
ASX - By Stock
|
ASN |
Re:
Ann: Quarterly Activities and Cashflow Report
|
|
charlirose
|
365 |
77K |
9 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
365
|
77K
|
9
|
|
ASX - By Stock
|
YOJ |
Re:
Ann: Quarterly Activities Report & Appendix 4C - Dec 2023
|
|
charlirose
|
1 |
740 |
1 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
1
|
740
|
1
|
|
ASX - By Stock
|
YOJ |
Re:
Ann: Consolidation/Split - YOJ
|
|
charlirose
|
12 |
8.1K |
4 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
12
|
8.1K
|
4
|
|
ASX - By Stock
|
ASN |
Re:
ASN General Discussion
|
|
charlirose
|
19K |
5.6M |
8 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
19K
|
5.6M
|
8
|
|
ASX - By Stock
|
ASN |
Re:
S.P prediction for 31 December.
|
|
charlirose
|
318 |
107K |
4 |
28/12/23 |
28/12/23 |
ASX - By Stock
|
318
|
107K
|
4
|
|
ASX - By Stock
|
5GN |
Re:
Ann: Webcentral Sale of Retail Domains and Hosting Business
|
|
charlirose
|
92 |
33K |
2 |
27/10/23 |
27/10/23 |
ASX - By Stock
|
92
|
33K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zeliras diabetic nerve pain drug outperforms Lyrica
|
|
charlirose
|
217 |
71K |
0 |
01/06/23 |
01/06/23 |
ASX - By Stock
|
217
|
71K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zeliras diabetic nerve pain drug outperforms Lyrica
|
|
charlirose
|
217 |
71K |
2 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
217
|
71K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zeliras diabetic nerve pain drug outperforms Lyrica
|
|
charlirose
|
217 |
71K |
14 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
217
|
71K
|
14
|
|
ASX - By Stock
|
ASN |
Re:
ASN General Discussion
|
|
charlirose
|
19K |
5.6M |
3 |
26/09/22 |
26/09/22 |
ASX - By Stock
|
19K
|
5.6M
|
3
|
|